当前位置：首页 SCI 期刊医学 Journal Of Infection And Public Health(非官网)

Journal Of Infection And Public HealthSCIE

国际简称：J INFECT PUBLIC HEAL 参考译名：感染与公共卫生杂志

中科院分区
3区
CiteScore分区
Q1
JCR分区
Q1

基本信息：: ISSN：1876-0341; E-ISSN：1876-035X; 是否OA：开放; 是否预警：否; TOP期刊：否

出版信息：: 出版地区：ENGLAND; 出版商：Elsevier BV; 出版语言：English; 出版周期：4 issues/year; 出版年份：2008; 研究方向：PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH -INFECTIOUS DISEASES

评价信息：: 影响因子：4.7; H-index：25; CiteScore指数：13.1; SJR指数：1.081; SNIP指数：1.225

发文数据：: Gold OA文章占比：95.65%; 研究类文章占比：84.69%; 年发文量：294; 自引率：0.0149...; 开源占比：0.9604; 出版撤稿占比：0; 出版国人文章占比：0.12; OA被引用占比：1

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Journal Of Infection And Public Health期刊介绍

The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.

The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners.

It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.

期刊简介Journal Of Infection And Public Health期刊介绍

《Journal Of Infection And Public Health》自2008出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间： 49 Weeks
医学
INFECTIOUS DISEASES
SCIE
中科院3区
非预警

Cite Score数据（2024年最新版）Journal Of Infection And Public Health Cite Score数据

CiteScore：13.1
SJR：1.081
SNIP：1.225

学科类别	分区	排名	百分位
大类：Medicine 小类：Public Health, Environmental and Occupational Health	Q1	22 / 665	96%
大类：Medicine 小类：Infectious Diseases	Q1	31 / 344	91%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Journal Of Infection And Public Health 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：否

大类学科	分区	小类学科	分区
医学	3区	INFECTIOUS DISEASES 传染病学 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 公共卫生、环境卫生与职业卫生	3区 3区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Journal Of Infection And Public Health JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：INFECTIOUS DISEASES	SCIE	Q1	20 / 132	85.2%
学科：PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH	SCIE	Q1	40 / 403	90.2%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：INFECTIOUS DISEASES	SCIE	Q1	19 / 132	85.98%
学科：PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH	SCIE	Q1	45 / 403	88.96%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
Saudi Arabia151
CHINA MAINLAND116
India79
USA66
Egypt42
Pakistan37
Italy30
Brazil25
Lebanon25
Turkey25

本刊中国学者近年发表论文

1、Perceptions, precautions, and vaccine acceptance related to monkeypox in the public in China: A cross-sectional survey
Author: Wang, Bingyi; Peng, Xin; Li, Yuwei; Fu, Leiwen; Tian, Tian; Liang, Bingyu; Sun, Yinghui; Chen, Yuanyi; Wu, Xinsheng; Liu, Qi; Lin, Yi-Fan; Meng, Xiaojun; Zou, Huachun

Journal: JOURNAL OF INFECTION AND PUBLIC HEALTH. 2023; Vol. 16, Issue 2, pp. 163-170. DOI: 10.1016/j.jiph.2022.12.010
2、Neurological Manifestations of hospitalized patients with mild to moderate infection with SARS-CoV-2 Omicron variant in Shanghai, China
Author: Shen, Xiaolei; Wang, Ping; Shen, Jun; Jiang, Yuhan; Wu, Li; Nie, Xin; Liu, Jianren; Chen, Wei

Journal: JOURNAL OF INFECTION AND PUBLIC HEALTH. 2023; Vol. 16, Issue 2, pp. 155-162. DOI: 10.1016/j.jiph.2022.12.005
3、Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
Author: Dhama, Kuldeep; Nainu, Firzan; Frediansyah, Andri; Yatoo, Mohd Iqbal; Mohapatra, Ranjan K.; Chakraborty, Sandip; Zhou, Hao; Islam, Md. Rabiul; Mamada, Sukamto S.; Kusuma, Hendrix Indra; Rabaan, Ali A.; Alhumaid, Saad; Al Mutair, Abbas; Iqhrammullah, Muhammad; Al-Tawfiq, Jaffar A.; Al Mohaini, Mohammed; Alsalman, Abdulkhaliq J.; Tuli, Hardeep Singh; Chakraborty, Chiranjib; Harapan, Harapan

Journal: JOURNAL OF INFECTION AND PUBLIC HEALTH. 2023; Vol. 16, Issue 1, pp. 4-14. DOI: 10.1016/j.jiph.2022.11.024
4、Brucella cultures characteristics, clinical characteristics, and infection biomarkers of human Brucellosis
Author: Feng, Qiangsheng; Ha, Xiaoqin; Lin, Tong; Guo, Wenyun; Song, Yuejuan

Journal: JOURNAL OF INFECTION AND PUBLIC HEALTH. 2023; Vol. 16, Issue 3, pp. 303-309. DOI: 10.1016/j.jiph.2023.01.002
5、Perceptions and worries about monkeypox, and attitudes towards monkeypox vaccination among medical workers in China: A cross-sectional survey
Author: Peng, Xin; Wang, Bingyi; Li, Yuwei; Chen, Yuanyi; Wu, Xinsheng; Fu, Leiwen; Sun, Yinghui; Liu, Qi; Lin, Yi-Fan; Liang, Bingyu; Fan, Yinguang; Zou, Huachun

Journal: JOURNAL OF INFECTION AND PUBLIC HEALTH. 2023; Vol. 16, Issue 3, pp. 346-353. DOI: 10.1016/j.jiph.2023.01.010
6、Cost-effectiveness of ceftazidime/avibactam plus metronidazole versus meropenem as first-line empiric therapy for the treatment of complicated intra-abdominal infections: A study based on the in-vitro surveillance data in China
Author: Shi, Xiaoping; Fu, Jie; Li, Xiaoyu; Lv, Qianzhou; Wan, Xu; Xu, Qing

Journal: JOURNAL OF INFECTION AND PUBLIC HEALTH. 2023; Vol. 16, Issue 3, pp. 361-367. DOI: 10.1016/j.jiph.2023.01.008
7、Fatal multisystem inflammatory syndrome in a 78-year-old adult after severe COVID-19 pneumonia during 2022 Omicron variant epidemic in Shanghai, China
Author: Su, Yang; Xing, Huan; Shen, Weijun; Li, Ming; Xu, Yawei; Li, Yingchuan

Journal: JOURNAL OF INFECTION AND PUBLIC HEALTH. 2023; Vol. 16, Issue 3, pp. 418-421. DOI: 10.1016/j.jiph.2023.01.003
8、Clinical and upper airway characteristics of 3715 patients with the Omicron variant of SARS-Cov-2 in Changchun, China
Author: Sha, Jichao; Meng, Cuida; Sun, Jing; Sun, Liwei; Gu, Rui; Liu, Junzhi; Zhu, Xuewei; Zhu, Dongdong

Journal: JOURNAL OF INFECTION AND PUBLIC HEALTH. 2023; Vol. 16, Issue 3, pp. 422-429. DOI: 10.1016/j.jiph.2023.01.013